Search

everythinglearnresearchcommunity

for

Search:↓

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

Hair loss from chemotherapy causes significant distress and affects social roles for ovarian and uterine cancer patients.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Paclitaxel chemotherapy causes premature aging and damage to hair follicles, potentially leading to permanent hair loss.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Reviewers suggest clarifying the abstract, adding background on inflammation's effect on cancer, discussing immune cell roles, including counter studies, and correcting grammar.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

ETS2 is crucial in squamous cell carcinoma development and could be a therapeutic target.

The PROCLIPI study found markers that help predict outcomes in skin lymphoma patients.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Blocking mTORC1 may help prevent skin cancer by stopping the growth of certain skin stem cells.

A 70-year-old man with skin cancer on both sides of his forehead was treated with surgery and cryotherapy, highlighting the need for early detection and prevention.

Hair helps prevent scalp skin cancer by supporting immune protection.

Lack of functional CYLD in mice leads to early aging and cancer.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

Neoplasms hide in hair follicles to avoid the immune system.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.